NCT06259838View on ClinicalTrials.gov

Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors.

CompletedOBSERVATIONAL

Enrollment

93

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 27, 2023

Study Completion Date

February 7, 2024

Conditions

Oral Cavity Squamous Cell Carcinoma; Readmission

Interventions

OTHER

no intervention

no intervention

Trial Locations (1)

21589

King Abdulaziz University Hospital, Jeddah

All Listed Sponsors

lead

Abdulsalam Alqutub

OTHER